Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Beth Faiman

Showing results (41-50 of 59) with videos related to

Pageof 6
Sort By:
Clinical Journal of Oncology Nursing|September 26, 2017
Distress, Fatigue, and Sexuality: Understanding and Treating Concerns and Symptoms in Patients With Multiple Myeloma 
Donna Catamero, Kimberly Noonan, Tiffany Richards, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 27, 2026
Past, Present, and Future of Dexamethasone in Multiple Myeloma and AL AmyloidosisRahul Banerjee, Tracy King, Beth Faiman, et al.
Cleveland Clinic Journal of Medicine|January 10, 2019
Monoclonal gammopathy of undetermined significance: A primary care guideJack Khouri, Christy Samaras, Jason Valent, et al.
Haematologica|September 12, 2006
The role of race, socioeconomic status, and distance traveled on the outcome of African-American patients with multiple myelomaRony M Abou-Jawde, Rachid Baz, Esteban Walker, et al.
Cancer Medicine|April 28, 2016
Lack of health maintenance examinations and risk in myeloma patientsJoseph D Tariman, Charise Gleason, Beth Faiman, et al.
Cancers|April 13, 2023
Management of Relapsed-Refractory Multiple Myeloma in the Era of Advanced Therapies: Evidence-Based Recommendations for Routine Clinical PracticeDanai Dima, Fauzia Ullah, Sandra Mazzoni, et al.
Hematological Oncology|April 13, 2025
Presentation and Outcomes of Localized Immunoglobulin Light Chain Amyloidosis: 14-Year Experience of an Academic CenterDanai Dima, Utkarsh Goel, Fauzia Ullah, et al.
Plos One|March 10, 2017
Neuropathy and efficacy of once weekly subcutaneous bortezomib in multiple myeloma and light chain (AL) amyloidosisSurbhi Sidana, Mayur Narkhede, Paul Elson, et al.
Cancers|May 27, 2026
Smoldering Multiple Myeloma: Early Intervention or Structured Surveillance? A Comprehensive Review of Evidence for and Against Early TherapyKirti Arora, Lara Soueid, Louis Williams, et al.
Mayo Clinic Proceedings|July 14, 2006
Phase 2 study of pegylated liposomal doxorubicin, vincristine, decreased-frequency dexamethasone, and thalidomide in newly diagnosed and relapsed-refractory multiple myelomaMohamad A Hussein, Rachid Baz, Gordan Srkalovic, et al.
Pageof 6

Showing results (41-50 of 59) with videos related to

Sort By:
Pageof 6
Clinical Journal of Oncology Nursing|September 26, 2017
Distress, Fatigue, and Sexuality: Understanding and Treating Concerns and Symptoms in Patients With Multiple Myeloma 
Donna Catamero, Kimberly Noonan, Tiffany Richards, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 27, 2026
Past, Present, and Future of Dexamethasone in Multiple Myeloma and AL AmyloidosisRahul Banerjee, Tracy King, Beth Faiman, et al.
Cleveland Clinic Journal of Medicine|January 10, 2019
Monoclonal gammopathy of undetermined significance: A primary care guideJack Khouri, Christy Samaras, Jason Valent, et al.
Haematologica|September 12, 2006
The role of race, socioeconomic status, and distance traveled on the outcome of African-American patients with multiple myelomaRony M Abou-Jawde, Rachid Baz, Esteban Walker, et al.
Cancer Medicine|April 28, 2016
Lack of health maintenance examinations and risk in myeloma patientsJoseph D Tariman, Charise Gleason, Beth Faiman, et al.
Cancers|April 13, 2023
Management of Relapsed-Refractory Multiple Myeloma in the Era of Advanced Therapies: Evidence-Based Recommendations for Routine Clinical PracticeDanai Dima, Fauzia Ullah, Sandra Mazzoni, et al.
Hematological Oncology|April 13, 2025
Presentation and Outcomes of Localized Immunoglobulin Light Chain Amyloidosis: 14-Year Experience of an Academic CenterDanai Dima, Utkarsh Goel, Fauzia Ullah, et al.
Plos One|March 10, 2017
Neuropathy and efficacy of once weekly subcutaneous bortezomib in multiple myeloma and light chain (AL) amyloidosisSurbhi Sidana, Mayur Narkhede, Paul Elson, et al.
Cancers|May 27, 2026
Smoldering Multiple Myeloma: Early Intervention or Structured Surveillance? A Comprehensive Review of Evidence for and Against Early TherapyKirti Arora, Lara Soueid, Louis Williams, et al.
Mayo Clinic Proceedings|July 14, 2006
Phase 2 study of pegylated liposomal doxorubicin, vincristine, decreased-frequency dexamethasone, and thalidomide in newly diagnosed and relapsed-refractory multiple myelomaMohamad A Hussein, Rachid Baz, Gordan Srkalovic, et al.
Pageof 6